Overview

Topical Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if lidocaine is effective in reducing the incidence of post-ERCP pancreatitis.
Phase:
N/A
Details
Lead Sponsor:
Abraham Mathew MD
Collaborator:
Milton S. Hershey Medical Center
Treatments:
Lidocaine